Gilead News
Most Popular Gilead Story
HIV guidelines spotlight Gilead drug
New HIV treatment guidelines from the U.S. government could give a boost to Gilead Sciences' med Truvada, a combo of its Emtriva and Viread treatments. And it disses GlaxoSmithKline's Truvada... Read more...
Latest Headlines
- November 4, 2008
- September 2, 2008
- August 12, 2008
- May 29, 2008
- April 28, 2008
- April 17, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
